Search hospitals > Kansas > Mission
University of Kansas Clinical Research Center
Claim this profileMission, Kansas 66205
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Lymphoma
Conducts research for Leukemia
Conducts research for Solid Tumors
152 reported clinical trials
45 medical researchers
Summary
University of Kansas Clinical Research Center is a medical facility located in Mission, Kansas. This center is recognized for care of Cancer, Tumors, Lymphoma, Leukemia, Solid Tumors and other specialties. University of Kansas Clinical Research Center is involved with conducting 152 clinical trials across 543 conditions. There are 45 research doctors associated with this hospital, such as Jun Zhang, Gary C. Doolittle, Chao H. Huang, and Jeffrey Statland.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Tumors
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Jun ZhangHouston Methodist Hospital4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
23 reported clinical trials
38 drugs studied
Gary C. DoolittleHaysMed University of Kansas Health System3 years of reported clinical research
Studies Cancer
Studies Melanoma
18 reported clinical trials
29 drugs studied
Chao H. HuangUniversity of Kansas Health System Saint Francis Campus5 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
18 reported clinical trials
30 drugs studied
Jeffrey StatlandUniversity of Kansas Medical Center1 year of reported clinical research
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
18 reported clinical trials
18 drugs studied
Clinical Trials running at University of Kansas Clinical Research Center
Acute Myeloid Leukemia
Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Pancreatic Cancer
Prostate Cancer
Bladder Carcinoma
Squamous Cell Carcinoma
Non-Hodgkin's Lymphoma
Renal Cell Carcinoma
CYAD-02
for Leukemia/Preleukemia
This study is evaluating whether a drug may help treat patients with acute myeloid leukemia or myelodysplastic syndrome.
Recruiting3 awards Phase 16 criteria
Targeted Therapies
for Acute Myeloid Leukemia
This study is evaluating whether genomic screening followed by assignment to a multi-study protocol may help identify new treatments for leukemia.
Recruiting1 award Phase 1 & 24 criteria
GLB-001
for Acute Myeloid Leukemia
Study GLB-001-01 is a first-in-human (FIH), Phase 1, open-label, dose escalation and expansion clinical study of GLB-001 in participants with relapsed or refractory acute myeloid leukemia (R/R AML) or in participants with relapsed or refractory higher-risk myelodysplastic syndromes (R/R HR-MDS). The dose escalation part (Phase 1a) of the study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary efficacy of GLB-001 administered orally. Approximately 24 participants (up to 42 participants) may be enrolled in Phase 1a of the study. The dose expansion part (Phase 1b) will be followed to understand the relationships among dose, exposure, toxicity, tolerability and clinical activity, to identify minimally active dose, and to select the recommended dose(s) for phase 2 study. Up to 24 participants (12 participants per dose level) may be enrolled in Phase 1b of the study.
Recruiting1 award Phase 16 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Kansas Clinical Research Center?
University of Kansas Clinical Research Center is a medical facility located in Mission, Kansas. This center is recognized for care of Cancer, Tumors, Lymphoma, Leukemia, Solid Tumors and other specialties. University of Kansas Clinical Research Center is involved with conducting 152 clinical trials across 543 conditions. There are 45 research doctors associated with this hospital, such as Jun Zhang, Gary C. Doolittle, Chao H. Huang, and Jeffrey Statland.